Valuation: PharmaEssentia Corporation

Market Cap 530B 16.5B 14.44B 13.32B 12.3B 23.34B 1,574B 23.73B 159B 62.48B 775B 61.97B 60.62B 2,666B P/E 2026 *
49.3x
P/E 2027 * 35.9x
Enterprise Value 503B 15.68B 13.71B 12.65B 11.68B 22.17B 1,495B 22.54B 151B 59.35B 737B 58.87B 57.59B 2,532B EV / Sales 2026 *
20.1x
EV / Sales 2027 * 14.3x
Free-Float
75.38%
Yield 2026 *
0.07%
Yield 2027 * 0.11%
1 day-6.84%
1 week+2.18%
Current month+6.37%
1 month+50.20%
3 months+120.65%
6 months+175.71%
Current year+203.28%
1 week 1,245
Extreme 1245
1,415.34
1 month 854.61
Extreme 854.6101
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 31/12/2002
Director of Finance/CFO - 13/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 31/08/2003
Director/Board Member - -
Director/Board Member - 29/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-6.84%+2.18%+195.12%+364.56% 16.5B
+1.84%-0.66%+59.82%+94.48% 54.88B
-4.14%-8.06%+58.96%+125.71% 54.63B
-2.24%+3.59%+17.75%+469.23% 25.06B
-1.60%-6.21%-18.96%-16.06% 23.14B
-0.11%0.00%+41.31%-7.13% 19.87B
-3.19%0.00%+35.60%-27.49% 17.55B
-5.91%-6.90%+42.18%+611.53% 15.75B
-1.05%+1.16%+25.95%+191.69% 14.2B
-4.16%+1.63%+70.13%+143.42% 12.37B
Average -2.74%-0.09%+52.79%+194.99% 25.39B
Weighted average by Cap. -2.17%-1.30%+51.49%+169.17%

Financials

2026 *2027 *
Net sales 25.07B 781M 683M 630M 582M 1.1B 74.49B 1.12B 7.53B 2.96B 36.7B 2.93B 2.87B 126B 34.57B 1.08B 942M 869M 803M 1.52B 103B 1.55B 10.38B 4.08B 50.6B 4.04B 3.96B 174B
Net income 10.85B 338M 296M 273M 252M 478M 32.25B 486M 3.26B 1.28B 15.89B 1.27B 1.24B 54.63B 14.97B 466M 408M 376M 348M 660M 44.49B 671M 4.5B 1.77B 21.92B 1.75B 1.71B 75.35B
Net Debt -26.52B -826M -723M -667M -616M -1.17B -78.82B -1.19B -7.97B -3.13B -38.83B -3.1B -3.04B -133B -34.73B -1.08B -946M -873M -806M -1.53B -103B -1.56B -10.43B -4.1B -50.84B -4.06B -3.97B -175B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
09/07/26 NT$1,285.00 -6.84% 6,711,957
08/07/26 NT$1,379.28 +2.34% 4,771,223
07/07/26 NT$1,347.72 +3.46% 3,959,953
06/07/26 NT$1,302.65 +3.58% 2,909,866
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,285.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-17.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock